Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket Pharmaceuticals (RCKT) Non Operating Income (2018 - 2019)

Updated

Rocket Pharmaceuticals (RCKT) recorded Non Operating Income of $2.48 million in FY2022, compared with -$1.82 million in FY2021.

Analysis

Rocket Pharmaceuticals (RCKT) Non Operating Income (2018 - 2019) Analysis & Trends

  • Per Business Quant data, RCKT's Non Operating Income was -$1.82 million in FY2021 and -$5.4 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -506,000.00
Mar 31, 2018 -938,000.00
API Access

Rocket Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=RCKT&period=max&api_key=YOUR_API_KEY